These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1712 related items for PubMed ID: 26316618

  • 1. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 2. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V.
    Heart Rhythm; 2018 Sep 27; 15(9):1379-1386. PubMed ID: 29678779
    [Abstract] [Full Text] [Related]

  • 3. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein HU, McNitt S, Zareba W, Goldenberg I.
    Pacing Clin Electrophysiol; 2018 Oct 27; 41(10):1307-1313. PubMed ID: 29992590
    [Abstract] [Full Text] [Related]

  • 4. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar 27; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 5. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 27; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 6. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 7. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death.
    Kutyifa V, Vermilye K, Daimee UA, McNitt S, Klein H, Moss AJ.
    Europace; 2018 Sep 01; 20(FI2):f225-f232. PubMed ID: 29905788
    [Abstract] [Full Text] [Related]

  • 8. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 01; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 9. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study.
    Garcia R, Combes N, Defaye P, Narayanan K, Guedon-Moreau L, Boveda S, Blangy H, Bouet J, Briand F, Chevalier P, Cottin Y, Da Costa A, Degand B, Deharo JC, Eschalier R, Extramiana F, Goralski M, Guy-Moyat B, Guyomar Y, Hermida JS, Jourda F, Lellouche N, Mahfoud M, Manenti V, Mansourati J, Martin A, Pasquié JL, Ritter P, Rollin A, Tibi T, Yalioua A, Gras D, Sadoul N, Piot O, Leclercq C, Marijon E.
    Europace; 2021 Jan 27; 23(1):73-81. PubMed ID: 33257972
    [Abstract] [Full Text] [Related]

  • 10. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK.
    J Heart Lung Transplant; 2015 Oct 27; 34(10):1305-9. PubMed ID: 26094085
    [Abstract] [Full Text] [Related]

  • 11. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 12. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
    Veltmann C, Winter S, Duncker D, Jungbauer CG, Wäßnig NK, Geller JC, Erath JW, Goeing O, Perings C, Ulbrich M, Roser M, Husser D, Gansera LS, Soezener K, Malur FM, Block M, Fetsch T, Kutyifa V, Klein HU.
    Clin Res Cardiol; 2021 Jan 04; 110(1):102-113. PubMed ID: 32377784
    [Abstract] [Full Text] [Related]

  • 13. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A, Kutyifa V, Vamvouris T, Moss AJ, Biton Y, Chen L, Storozynsky E, Wan C, Szymkiewicz SJ, Goldenberg I.
    J Cardiovasc Electrophysiol; 2017 Jul 04; 28(7):778-784. PubMed ID: 28429542
    [Abstract] [Full Text] [Related]

  • 14. Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry.
    El-Battrawy I, Kovacs B, Dreher TC, Klein N, Rosenkaimer S, Röger S, Kuschyk J, Saguner AM, Kowitz J, Erath JW, Duru F, Akin I.
    Sci Rep; 2022 Feb 25; 12(1):3203. PubMed ID: 35217697
    [Abstract] [Full Text] [Related]

  • 15. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG.
    Pacing Clin Electrophysiol; 2014 May 25; 37(5):562-8. PubMed ID: 24762055
    [Abstract] [Full Text] [Related]

  • 16. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.
    Circ Arrhythm Electrophysiol; 2018 Jul 25; 11(7):e006163. PubMed ID: 29945928
    [Abstract] [Full Text] [Related]

  • 17. Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.
    Singh M, Wang NC, Jain S, Voigt AH, Saba S, Adelstein EC.
    J Am Coll Cardiol; 2015 Dec 15; 66(23):2607-2613. PubMed ID: 26670060
    [Abstract] [Full Text] [Related]

  • 18. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
    Duncker D, Haghikia A, König T, Hohmann S, Gutleben KJ, Westenfeld R, Oswald H, Klein H, Bauersachs J, Hilfiker-Kleiner D, Veltmann C.
    Eur J Heart Fail; 2014 Dec 15; 16(12):1331-6. PubMed ID: 25371320
    [Abstract] [Full Text] [Related]

  • 19. Age differences of patients treated with wearable cardioverter defibrillator: Data from a multicentre registry.
    El-Battrawy I, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, Klein N, Shin DI, Hijazi M, Rosenkaimer S, Beiert T, Abumayyaleh M, Saguner AM, Kowitz J, Erath JW, Duru F, Mügge A, Aweimer A, Akin I.
    Eur J Clin Invest; 2023 Jul 15; 53(7):e13977. PubMed ID: 36852491
    [Abstract] [Full Text] [Related]

  • 20. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.
    J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 86.